Abiopharma

MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium

LECTRA : Déclaration mensuelle du nombre total dactions et de droits de vote composant le capital social (au 31 juillet 2026)

Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company

Theriva™ Biologics anuncia que se ha administrado la primera dosis a un paciente en el ensayo clínico VIRAGE2 de Fase IIa, destinado a evaluar una administración más frecuente de VCN-01 (zabilugene almadenorepvec) en pacientes en tratamiento de primera línea con adenocarcinoma ductal pancreático metastásico

Chemed Corporation Declares Quarterly Dividend of 70 Cents

Dogfish Head to Host Dog & Owner Lookalike Contest this National Dog Day

Elong Power Holding Limited Announces the Change of Effective Date of its 1 for 45 Share Consolidations

MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2026

KLÉPIERRE RELEASES ITS FIRST-HALF 2026 FINANCIAL REPORT

Donaldson to Webcast Fourth Quarter Fiscal 2026 Earnings Conference Call

Monthly disclosure on share capital and voting rights on July 31, 2026

Déclaration mensuelle relative au nombre total de droits de vote et dactions composant le capital social au 31 juillet 2026

Fulfillment of suspensive conditions regarding Rami Levy Club – Israir

General Announcement: ESG Report 2025

The suspensive conditions set forth in the agreements for the establishment of an aviation club with Isracard and Israir Aviation and Tourism and the Rami Levy club have been fulfilled.